Clinical Trials
6
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
ConsideRAte Study - Splenic Stimulation for RA
- Conditions
- Rheumatoid Arthritis
- Interventions
- First Posted Date
- 2021-08-12
- Last Posted Date
- 2024-05-22
- Lead Sponsor
- Galvani Bioelectronics
- Target Recruit Count
- 28
- Registration Number
- NCT05003310
- Locations
- 🇺🇸
Pinnacle Research Group, LLC, Anniston, Alabama, United States
🇺🇸Medvin Research - Covina, Covina, California, United States
🇺🇸Medvin Research - Whittier, Whittier, California, United States
Safety of Splenic Stimulation for RA
- Conditions
- Rheumatoid Arthritis
- First Posted Date
- 2021-07-09
- Last Posted Date
- 2024-02-14
- Lead Sponsor
- Galvani Bioelectronics
- Target Recruit Count
- 5
- Registration Number
- NCT04955899
- Locations
- 🇳🇱
Academic Medical Center (AMC) Dept of Rheumatology & Clinical Immunology, Amsterdam, Netherlands
🇬🇧Greater Glasgow Health Board, Glasgow, United Kingdom
Nerve Stimulation During Esophagectomy
- Conditions
- Inflammatory Response
- First Posted Date
- 2019-11-20
- Last Posted Date
- 2020-10-29
- Lead Sponsor
- Galvani Bioelectronics
- Target Recruit Count
- 14
- Registration Number
- NCT04171011
- Locations
- 🇳🇱
Catharina Ziekenhuis, Eindhoven, Netherlands
News
Verily Partners with Dutch Institutions to Launch Large-Scale Parkinson's Disease Study
Google's life sciences division Verily collaborates with Radboud University Medical Center and ParkinsonNet to study disease progression in 650 Parkinson's patients using advanced imaging and wearable technology.